These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15119047)

  • 61. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Specific immunotherapy with tablets].
    Krankenpfl J; 2005; 43(7-10):260. PubMed ID: 16515331
    [No Abstract]   [Full Text] [Related]  

  • 63. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Polymerized whole ragweed: A two-year follow-up of patients treated with an improved method of immunotherapy.
    Hendrix S; Zeiss CR; Levitz D; Suszko IM; Patterson R
    J Allergy Clin Immunol; 1980 Jan; 65(1):57-60. PubMed ID: 7350204
    [No Abstract]   [Full Text] [Related]  

  • 65. [Immunotherapy in allergology].
    Rogala B
    Pol Merkur Lekarski; 2003 Jun; 14(84):705-7. PubMed ID: 14524311
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vitiligo Induced by Specific Immunotherapy With Grass Pollen: The Koebner Phenomenon.
    Rodríguez-Jiménez B; Muñoz-García E; Veza Perdomo S; González Herrada C; Kindelán-Recarte C; Domínguez-Ortega J
    J Investig Allergol Clin Immunol; 2016; 26(5):331-332. PubMed ID: 27763866
    [No Abstract]   [Full Text] [Related]  

  • 67. Hay fever plants in Oklahoma.
    Levetin E; Buck P
    Ann Allergy; 1980 Jul; 45(1):26-32. PubMed ID: 7406241
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preventive aspects of specific immunotherapy.
    Jacobsen L
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):141-5. PubMed ID: 15119031
    [No Abstract]   [Full Text] [Related]  

  • 69. [Oral immunotherapy versus parenteral immunotherapy].
    Romo A; Lorente F; Romo MT; García MJ; Lorenzo C
    Allergol Immunopathol (Madr); 1996; 24 Suppl 1():92-103. PubMed ID: 8815728
    [No Abstract]   [Full Text] [Related]  

  • 70. [Bacteriotherapy and stimulation therapy inspite, instead and with chemotherapy].
    Elkeles G
    Med Klin; 1967 Jun; 62(25):982-5. PubMed ID: 5302001
    [No Abstract]   [Full Text] [Related]  

  • 71. Not to be sneezed at.
    McManus L; Hosie P
    J Fam Health Care; 2014 Jun; 24(4):18-20, 22. PubMed ID: 25112045
    [No Abstract]   [Full Text] [Related]  

  • 72. Recall urticaria: a case report.
    Karaayvaz M; Ozangüç N
    J Allergy Clin Immunol; 1996 Jun; 97(6):1419-20. PubMed ID: 8648043
    [No Abstract]   [Full Text] [Related]  

  • 73. [Contribution to the therapy of rhinopathia vasomotorica].
    Jents E; Yppen E
    Wien Klin Wochenschr; 1967 Jul; 79(27):574. PubMed ID: 5592607
    [No Abstract]   [Full Text] [Related]  

  • 74. White willow.
    Weber RW
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):A6. PubMed ID: 14989384
    [No Abstract]   [Full Text] [Related]  

  • 75. Western aspen.
    Weber RW
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):A4. PubMed ID: 11345296
    [No Abstract]   [Full Text] [Related]  

  • 76. IgE-based immunotherapy of cancer: challenges and chances.
    Singer J; Jensen-Jarolim E
    Allergy; 2014 Feb; 69(2):137-49. PubMed ID: 24117861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rinkel technique.
    Gerdes KA
    J Allergy Clin Immunol; 1982 Feb; 69(2):253. PubMed ID: 7056956
    [No Abstract]   [Full Text] [Related]  

  • 78. Paging Dr Google: What do patients search for when pollen counts are high?
    Pat V; Kosisky SE; Keswani A
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):203-205. PubMed ID: 33152474
    [No Abstract]   [Full Text] [Related]  

  • 79. Specific suppression of IgE antibodies. An immunotherapeutic goal achievable in the foreseeable future.
    Sehon AH
    J Allergy Clin Immunol; 1978 Nov; 62(5):257-60. PubMed ID: 701660
    [No Abstract]   [Full Text] [Related]  

  • 80. In This Issue: Translational Opportunities for Antibodies: Therapeutics, Biomarkers, and Novel Targets.
    Bot A; Kumar H
    Int Rev Immunol; 2016 Jul; 35(4):291-293. PubMed ID: 27797621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.